ClinicalTrials.gg
CompletedNCT07374900Updated Aug 7, 2026

Hybrid Versus In-clinic Rehabilitation for Non-traumatic Shoulder Pain in Routine Care.

An observational study in Shoulder Pain, sponsored by Universidad Pública de Navarra. Completed at 1 site in Spain. Open to participants aged 18 Years to 71 Years. Per ClinicalTrials.gov, last updated 2026-08-07.

Sponsored by Universidad Pública de Navarra · Observational

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
159
Ages
18 Years to 71 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 52 studies in Shoulder Pain with a site in Spain — 10 open to participants now, 10 under way, none of them phase 3. Shoulder Pain · Spain.

Started
2025
with 5 others
Observational
3 of 52
none open now
Registered
49th of 52
by date

Among the 52 studies in Shoulder Pain with a site in Spain, this one is one of 6 that started in 2025, is one of 3 observational ones, and was the 49th registered.

Shoulder Pain

738 studies on the registry are indexed under Shoulder Pain; 168 are open to participants now.

Browse Shoulder Pain studies →

Open to participants now

10 of the 52 studies in Shoulder Pain with a site in Spain are open now. Recruiting first, the newest first:

5 more — sign in →

All 10 open studies →

A study can be open while its sites in Spain have not opened yet or have stopped. Only those recruiting at a site in Spain →

Who these studies take

Of the 90 Shoulder Pain studies recruiting now, 25 (28%) set no upper age limit and 55 (61%) stop at 75 or younger; 3 take children under 18; 15 take healthy volunteers.

This study: 18 Years to 71 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 52 studies in Shoulder Pain with a site in Spain, or all of them as a file.
02

Study summary

This prospective longitudinal observational cohort study compared feasibility-allocated hybrid and in-clinic rehabilitation for adults with non-traumatic shoulder pain or dysfunction managed within the same standardized web- and mobile-supported semi-automated shoulder rehabilitation system (WMSSR). The primary outcome was observed time from baseline to documented clinical discharge among completed rehabilitation episodes. Secondary outcomes included total clinical deficit score, maximum pain per visit, number of painful tests per visit, Constant-Murley score at discharge, and adherence to prescribed rehabilitation sessions.

Read the detailed description

This prospective consecutive observational study was conducted in routine outpatient care at TDN Clínica (Navarra, Spain) to assess whether outcomes differ between two physiotherapy delivery formats for adults with non-traumatic shoulder pain/dysfunction managed within the same standardized web- and mobile-supported semi-automated shoulder rehabilitation system (WMSSR) between March and September 2025 and followed within the study until 11 November 2025. Allocation to format was feasibility-based (non-random) according to routine-care constraints (e.g., work schedule, transport, distance). Both formats were delivered at a nominal frequency of three sessions/week: hybrid (1 supervised in-person session plus 2 unsupervised home sessions supported by smartphone access to prescribed exercises) and in-clinic rehabilitation (3 supervised in-clinic sessions/week).

WMSSR integrates a structured assessment-prescription-reassessment process. Patients completed a standardized 24-test functional battery at baseline (visit 1) and at follow-up evaluations scheduled every 3-5 weeks until clinical discharge. The battery includes measures of strength (digital dynamometry), range of motion (manual goniometry), flexibility, and clinical tests. Pain intensity during test performance was recorded using a 0-10 visual analogue scale (VAS). Pain-related variables included maximum pain per visit, the number of test records with VAS >0 within the 24-test assessment, and a composite VAS used to summarize episode-level pain burden and support discharge assessment. Test scoring yields a total clinical deficit score. Clinical discharge was defined within the workflow using explicit criteria (deficit score threshold, symmetric strength, functional ROM, and low pain during tests).

Study objectives:

1) To describe and compare observed time from baseline to documented clinical discharge among completed rehabilitation episodes managed with hybrid versus in-clinic rehabilitation.

(2) To describe and compare discharge total clinical deficit score and Constant-Murley score between rehabilitation modalities.

(3) To describe longitudinal changes in maximum pain and the number of painful tests across assessment visits in both rehabilitation modalities.

(4) To describe adherence to prescribed rehabilitation sessions in each rehabilitation modality.

03

Conditions studied

  • Shoulder Pain

Browse trials for

Keywords

  • shoulder pain
  • physiotherapy
  • hybrid rehabilitation
  • home exercise
  • real-world evidence
  • shoulder dysfunction
  • in-clinic rehabilitation
  • digital rehabilitation
  • WMSSR
  • time to clinical discharge
04

Who can participate

Ages eligible
18 Years to 71 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Adults aged 18-71 years with non-traumatic shoulder pain or dysfunction persisting for more than 3 months were recruited through social media and institutional email invitations, screened for eligibility, and enrolled in routine outpatient care at TDN Clínica in Noáin, Navarra, Spain. All enrolled participants had access to a smartphone and entered the standardized WMSSR digital rehabilitation workflow. Rehabilitation modality was determined according to the practical feasibility of attending three supervised in-clinic sessions per week. The enrolled cohort comprised 159 participants contributing 164 initiated rehabilitation episodes.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Non-traumatic shoulder pain or dysfunction persisting for more than 3 months before study entry
  • Access to a smartphone to view the prescribed exercise instructions

Exclusion criteria

Exclusion Criteria:

  • Acute fractures or dislocations
  • Arthritis/osteoarthritis
  • Osteosarcoma or osteomyelitis
  • Recent shoulder surgery
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
159 participants (actual)
Patient registry
No

Groups and cohorts

  • Group 1: Hybrid rehabilitation

    One supervised in-clinic session plus two unsupervised home-based sessions per week. Clinical reassessments were performed face to face every 3-5 weeks, and the exercise prescription was updated according to the participant's clinical evolution.

  • Group 2: In-clinic rehabilitation

    Description: Three supervised in-clinic sessions per week. Clinical reassessments were performed face to face every 3-5 weeks, and the exercise prescription was updated according to the participant's clinical evolution.

06

What researchers measure

Primary outcomes

  1. Observed time to documented clinical discharge among completed rehabilitation episodes

    Number of days from the baseline visit (V1) to documented clinical discharge. This outcome was analyzed among rehabilitation episodes with a documented discharge event within the predefined study window. Episodes that discontinued treatment or remained under active follow-up at database closure did not have an observed discharge outcome and were summarized separately.

    Time frame: From baseline visit (V1) to documented clinical discharge, up to 200 days

Secondary outcomes

  1. Change in total clinical deficit score from baseline to discharge

    The total clinical deficit score was calculated from the standardized 24-test shoulder assessment and ranged from 0 to 36 points, with higher scores indicating greater clinical impairment. Change was calculated as baseline score minus discharge score; therefore, positive values indicate a reduction in clinical deficit. The analysis included rehabilitation episodes with paired baseline and documented discharge assessments.

    Time frame: Baseline visit (V1) and documented clinical discharge, up to 200 days after baseline

  2. Maximum pain per visit during rehabilitation

    Pain during test performance was recorded using a 0-10 visual analogue scale (VAS), where 0 indicates no pain and 10 indicates the greatest pain intensity. Maximum pain per visit was defined as the highest VAS value recorded across the test records completed at a given assessment visit. Values were summarized at baseline, across scheduled reassessments, and at documented clinical discharge. Lower values indicate less pain.

    Time frame: At baseline, at face-to-face reassessments scheduled every 3-5 weeks, and at documented clinical discharge, up to 200 days after baseline

  3. Number of painful tests per visit during rehabilitation

    The number of painful tests per visit was defined as the count of test records with VAS \>0 within the standardized 24-test shoulder assessment. One episode-level count was calculated for each assessment visit. Values were summarized at baseline, across scheduled reassessments, and at documented clinical discharge. Lower counts indicate fewer painful responses during the assessment.

    Time frame: At baseline, at face-to-face reassessments scheduled every 3-5 weeks, and at documented clinical discharge, up to 200 days after baseline

  4. Constant-Murley score at clinical discharge

    The Constant-Murley score was recorded at documented clinical discharge as an additional measure of shoulder functional status. The score ranges from 0 to 100 points, with higher values indicating better shoulder function. It was measured at discharge only and was not included among the predefined clinical discharge criteria.

    Time frame: At documented clinical discharge, up to 200 days after baseline

  5. Adherence to prescribed rehabilitation sessions

    Episode-level rehabilitation adherence was calculated as the percentage of prescribed rehabilitation sessions completed during the rehabilitation episode: (number of completed prescribed sessions / total number of prescribed sessions) × 100. In the hybrid group, prescribed sessions included one supervised in-clinic session and two unsupervised home-based sessions per week. In the in-clinic group, prescribed sessions included three supervised in-clinic sessions per week. Higher percentages indicate greater adherence.

    Time frame: Throughout the rehabilitation episode, from baseline until documented clinical discharge, up to 200 days

07

Study locations

1 site
  • TDN Clínica Traumatología y Rehabilitación SLP
    Noaín, Navarre 31110, Spain
08

References and documents

Publications

  • Setuain I, Gonzalez-Izal M, Paularena A, Luque JL, Andersen LL, Izquierdo M. A protocol for a new methodological model for work-related shoulder complex injuries: From diagnosis to rehabilitation. BMC Musculoskelet Disord. 2017 Feb 7;18(1):70. doi: 10.1186/s12891-017-1435-2. PubMed 28173784 ↗

Individual participant data

Plan to share: No — At present, there is no plan to share individual participant data (IPD). This is a single-center study with a relatively small sample and detailed clinical assessments, which may increase the risk of re-identification, and the original informed consent did not explicitly cover broad IPD sharing. De-identified summary results will be available in the published manuscript, and additional aggregated information may be considered upon reasonable request.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Mar 2025 to primary completion in Nov 2025, 7 months.

Of 49 non-industry observational studies under Shoulder Pain, half reached primary completion within 10 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 24. This study's 7 months is below that.

Counting every sponsor, half of 54 studies reached it within 12 months; a quarter within 4 and three quarters within 35.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 15, 2026
First posted
Jan 29, 2026
StartActual
Mar 17, 2025
Primary completionActual
Nov 11, 2025
CompletionActual
Nov 11, 2025
Last update
Aug 7, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 7, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07374900
Lead sponsor
Universidad Pública de Navarra
Responsible party
Sponsor
First posted
Jan 29, 2026
Start date
Mar 17, 2025
Primary completion
Nov 11, 2025
Completion
Nov 11, 2025
Last update
Aug 7, 2026

Study contacts

José A Sanz, PHD
study director · Universidad Pública de Navarra
Igor Setuain, PHD
study director · TDN Clinica
Iban Latasa, PHD
study director · IED Electronics

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion